Cargando…

If we designed airplanes like we design drugs…

In the early days, airplanes were put together with parts designed for other purposes (bicycles, farm equipment, textiles, automotive equipment, etc.). They were then flown by their brave designers to see if the design would work—often with disastrous results. Today, airplanes, helicopters, missiles...

Descripción completa

Detalles Bibliográficos
Autor principal: Woltosz, Walter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268976/
https://www.ncbi.nlm.nih.gov/pubmed/22139474
http://dx.doi.org/10.1007/s10822-011-9490-5
_version_ 1782222430853398528
author Woltosz, Walter S.
author_facet Woltosz, Walter S.
author_sort Woltosz, Walter S.
collection PubMed
description In the early days, airplanes were put together with parts designed for other purposes (bicycles, farm equipment, textiles, automotive equipment, etc.). They were then flown by their brave designers to see if the design would work—often with disastrous results. Today, airplanes, helicopters, missiles, and rockets are designed in computers in a process that involves iterating through enormous numbers of designs before anything is made. Until very recently, novel drug-like molecules were nearly always made first like early airplanes, then tested to see if they were any good (although usually not on the brave scientists who created them!). The resulting extremely high failure rate is legendary. This article describes some of the evolution of computer-based design in the aerospace industry and compares it with the progress made to date in computer-aided drug design. Software development for pharmaceutical research has been largely entrepreneurial, with only relatively limited support from government and industry end-user organizations. The pharmaceutical industry is still about 30 years behind aerospace and other industries in fully recognizing the value of simulation and modeling and funding the development of the tools needed to catch up.
format Online
Article
Text
id pubmed-3268976
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-32689762012-02-16 If we designed airplanes like we design drugs… Woltosz, Walter S. J Comput Aided Mol Des Perspective In the early days, airplanes were put together with parts designed for other purposes (bicycles, farm equipment, textiles, automotive equipment, etc.). They were then flown by their brave designers to see if the design would work—often with disastrous results. Today, airplanes, helicopters, missiles, and rockets are designed in computers in a process that involves iterating through enormous numbers of designs before anything is made. Until very recently, novel drug-like molecules were nearly always made first like early airplanes, then tested to see if they were any good (although usually not on the brave scientists who created them!). The resulting extremely high failure rate is legendary. This article describes some of the evolution of computer-based design in the aerospace industry and compares it with the progress made to date in computer-aided drug design. Software development for pharmaceutical research has been largely entrepreneurial, with only relatively limited support from government and industry end-user organizations. The pharmaceutical industry is still about 30 years behind aerospace and other industries in fully recognizing the value of simulation and modeling and funding the development of the tools needed to catch up. Springer Netherlands 2011-12-03 2012 /pmc/articles/PMC3268976/ /pubmed/22139474 http://dx.doi.org/10.1007/s10822-011-9490-5 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Perspective
Woltosz, Walter S.
If we designed airplanes like we design drugs…
title If we designed airplanes like we design drugs…
title_full If we designed airplanes like we design drugs…
title_fullStr If we designed airplanes like we design drugs…
title_full_unstemmed If we designed airplanes like we design drugs…
title_short If we designed airplanes like we design drugs…
title_sort if we designed airplanes like we design drugs…
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268976/
https://www.ncbi.nlm.nih.gov/pubmed/22139474
http://dx.doi.org/10.1007/s10822-011-9490-5
work_keys_str_mv AT woltoszwalters ifwedesignedairplaneslikewedesigndrugs